[1] BAUMGARTNER K,KBLER J,BITZER M,et al. Caroli’s syndrome[J]. Rofo,2020,192(2):119-122.
|
[2] MOSLIM MA,GUNASEKARAN G,VOGT D,et al. Surgical management of Caroli’s disease:Single center experience and review of the literature[J]. J Gastrointest Surg,2015,19(11):2019-2027.
|
[3] YONEM O,BAYRAKTAR Y. Clinical characteristics of Caroli’s syndrome[J]. World J Gastroenterol,2007,13(13):1934-1937.
|
[4] KERKAR N,NORTON K,SUCHY FJ. The hepatic fibrocystic diseases[J]. Clin Liver Dis,2006,10(1):55-71,v-vi.
|
[5] PARADA LA,HALLN M,HGERSTRAND I,et al. Clonal chromosomal abnormalities in congenital bile duct dilatation(Caroli’s disease)[J]. Gut,1999,45(5):780-782.
|
[6] OBUSEZ EC,UDAYASANKAR U. Autosomal recessive polycystic kidney disease with Caroli syndrome[J]. J Urol,2015,193(2):679-680.
|
[7] HAN X,DING XL,LI XM,et al. Gastrointestinal bleeding induced by Caroli disease:A case report[J]. J Clin Hepatol,2020,36(1):169-170.(in Chinese)韩西,丁晓玲,李雪梅,等.Caroli病引发上消化道出血1例报告[J].临床肝胆病杂志,2020,36(1):169-170.
|
[8] FAHRNER R,DENNLER S,DONDORF F,et al. Liver resection and transplantation in Caroli disease and syndrome[J]. J Visc Surg,2019,156(2):91-95.
|
[9] WU X,WU MJ,LUO SQ,et al. Clinical characteristics of Caroli disease typeⅠandⅡ—analysis of 78 cases[J]. Gastroenterology,2016,21(7):424-428.(in Chinese)吴欣,吴孟晋,罗生强,等.Caroli病Ⅰ、Ⅱ型的临床特征—78例分析[J].胃肠病学,2016,21(7):424-428.
|
[10] CNOSSEN WR,DRENTH JP. Polycystic liver disease:An overview of pathogenesis,clinical manifestations and management[J]. Orphanet J Rare Dis,2014,9:69.
|
[11] CHEN GY,NUEZ G. Sterile inflammation:Sensing and reacting to damage[J]. Nat Rev Immunol,2010,10(12):826-837.
|
[12] LI YY,TIAN SF,CAI YX,et al. Clinicopathological characteristics and literature review of Caroli disease[J]. J Wuhan Univ(Medical Edition),2020,41(1):149-152.(in Chinese)李跃莹,田素芳,蔡宇翔,等.Caroli病的临床病理特征及文献复习[J].武汉大学学报(医学版),2020,41(1):149-152.
|
[13] ZHANG Y,YU YS,TANG ZH,et al. Clinical value of combined detection of serum retinol binding protein,prealbumin and albumin in patients with hepatitis B cirrhosis[J]. J Clin Hepatol,2009,25(6):422-424.(in Chinese)张毅,余永胜,汤正好,等.乙肝肝硬化患者联合检测血清视黄醇结合蛋白、前白蛋白和白蛋白的临床价值[J].临床肝胆病杂志,2009,25(6):422-424.
|
[14] DESMET VJ. Ludwig symposium on biliary disorders--part I. Pathogenesis of ductal plate abnormalities[J]. Mayo Clin Proc,1998,73(1):80-89.
|
[15] WANG J,ZHENG GZ. Analysis of factors related to rupture and bleeding of esophageal varices due to liver cirrhosis[J/CD].Chin J Hepatol(Electronic Edition),2019,11(1):42-46.(in Chinese)王娟,郑鸽之.肝硬化食管静脉曲张破裂出血相关因素分析[J/CD].中国肝脏病杂志(电子版),2019,11(1):42-46.
|
[16] XIONG Z,LIU YY,HUO SK,et al. Research advances in vitamin K1 in treatment of coagu-lopathy of liver failure[J]. J Clin Hepatol,2019,35(9):2099-2103.(in Chinese)熊壮,刘扬扬,霍少凯,等.维生素K1治疗肝衰竭凝血功能障碍的研究进展[J].临床肝胆病杂志,2019,35(9):2099-2103.
|
[17] ZHAO YX,CAO MB. Analysis of risk factors related to cirrhosis complicated with esophageal varices bleeding[J]. J Xin xiang Med Coll,2018,35(10):869-873.(in Chinese)赵迤璇,曹名波.肝硬化并发食管静脉曲张破裂出血的相关危险因素分析[J].新乡医学院学报,2018,35(10):869-873.
|